Michael A. Metzger
Chief Executive Officer at Syndax Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Syndax Pharmaceuticals Inc., 3 years.
Syndax Pharmaceuticals Inc.
Director · Chief Executive Officer
Pyxis Oncology Inc.
Director
Chief executive roles
Syndax Pharmaceuticals Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 7, 2024 | Syndax Pharmaceuticals Inc. | Grant or award | +107,250 | — | — |
| Feb 7, 2024 | Syndax Pharmaceuticals Inc. | Grant or award | +39,000 | — | — |
| Feb 6, 2023 | Syndax Pharmaceuticals Inc. | Option exercise | +5,959 | $6.38 | $38,018 |
| Feb 6, 2023 | Syndax Pharmaceuticals Inc. | Open-market sale | −5,959 | $27.64 | $164,707 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.